Our mission is to help early-stage biotech founders turn promising ideas into fundable, testable, and market-ready ventures.
We help early-stage biotech founders develop fundable ideas, strong grant proposals, and clear commercialization paths.
We engineer investor readiness for pre-seed life science startups. Through specialized SBIR/STTR non-dilutive funding strategy, commercialization planning, and structured ecosystem alliances, we transform academic innovators into fundable enterprise leaders.
Rigorous Innovation
We meet scientist-founders where they are — at the whiteboard, the bench, or the pitch deck — and walk with them from discovery to fundable company.
We believe the best science deserves the best strategy. Rigor and ambition are not opposites, they are partners. We believe that deep scientific breakthroughs deserve equally rigorous commercial strategies. We marry analytical precision with ecosystem execution to eliminate the friction of market entry.
Dr. Baindu Bayon Paicely is a scientist turned strategist with over a decade of experience driving translational science strategy and organizational alignment across the biotech, government, and academic sectors.
As an advocate for the commercialization of science, Dr. Bayon Paicely is an Adjunct Professor, where she teaches biotechnology and mentors the next generation of scientific founders. She has also served as an Entrepreneur-in-Residence and as a Principal Small Business Consultant, coaching dozens of high-growth startups and securing federal funding for underrepresented founders.
Dr. Bayon Paicely most recently served as the Senior Manager of Strategic Partnerships at VentureWell and the network lead for the ARPA-H Investor Catalyst Hub. In this role, she orchestrated the ecosystem growth strategy for a national network of over 700 academic research institutions, hospital systems, and investors, acting as a primary liaison between federal innovation leadership and private sector stakeholders to accelerate "healthcare moonshots".
Her deep scientific curiosity is rooted in her PhD in Medical & Molecular Genetics, where her doctoral research focused on the neurogenetics of Alzheimer’s disease and transcription factor regulation. She began her professional journey in the laboratories of large pharma, supporting drug discovery across multiple therapeutic areas. Dr. Bayon Paicely served as AAAS Science & Technology Policy Fellow at the National Institutes of Health (NIH) Small business Education and Entrepreneurial Development (SEED) office and as a member of the National Academies of Sciences, Engineering, and Medicine (NASEM) New Voices.
Recognized for her impact and leadership, Dr. Bayon Paicely was named to the Indianapolis Business Journal’s "40 Under 40" and has been honored as a "Hero" by the United Way of Central Indiana. She serves on several advisory boards, continuing her commitment to inclusive discovery and the success of biotechnology from ideation to launch.
Her mission is to help scientist-founders validate faster, pitch better, and build companies the world actually needs.
Meet the Founder
Ready to Reimagine Your Growth?
Submit the form below and let’s pioneer the future of your business together.